anti-Mucin 7, Secreted (MUC7) Anticorps

Human Mucin 7, Secreted (MUC7) interaction partners

1. The genotypic polymorphisms of IL-1beta (Montrer IL1B Anticorps) -511 and +3954, and of MUC7 VNTR, had no direct associations with the development of BMS. However, the T allele of IL-1beta (Montrer IL1B Anticorps) -511 may increase the risk of BMS by increasing psychological asthenia.

2. High expression of MUC7 is associated with clear-cell renal cell carcinoma (Montrer MOK Anticorps).

3. A capsule-free mutant of S. pneumoniae TIGR4 binds to salivary proteins, most prominently to mucin (Montrer SLC13A2 Anticorps) MUC7, but that this binding was not mediated through PsrP or recognition of sialic acid.

4. MUC7 glycosylation is altered in recurrent aphthous stomatitis. This may change the protective properties of this mucin (Montrer SLC13A2 Anticorps) against mucosal pathogens, which may effect this condition.

5. Results identified a reduction in glycosylation of MUC7 in Sjogren's primarily due to the loss of the extended core 2 disialylated structure, with and without fucosylation and suggest that MUC7 O-glycan changes in Sjogren's Syndrome may alter the physical properties of saliva (Montrer RAG1AP1 Anticorps), leading to the symptom of dry mouth.

6. The minimally invasive PTT procedure combined with Mucin 7 targeted GNPs is able to kill cancer cells and preserve healthy cells

7. MUC7 is a salivary mucin (Montrer SLC13A2 Anticorps) with antimicrobial activity against bacteria and fungi.

8. A significant increase in sulfation was identified in salivary MUC7 from rheumatoid arthritis patients.

9. The study did not show a correlation between the MUC7 genotypes and caries.

10. The present study did not disclose an association between MUC7*5/*6 and MUC7*6/*6 genotypes and gingival bleeding index.